Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. IVA
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
IVA
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

IVA Similar Chart Price Prediction

The price of IVA is predicted to go up -6.08%, based on the high correlation periods with NKSH. The similarity of these two price pattern on the periods is 96.65%.

stocks logo

IVA

stocks logo

NKSH

Down: -6.08%Similarity: 96.65%

IVA Revenue Forecast

IVA EPS Forecast

IVA FAQs

What is bull’s view on IVA?

IVA stock has a bullish outlook, with analysts from HC Wainwright and Stifel maintaining "Strong Buy" ratings and price targets of $13 and $17, respectively, indicating significant upside potential from the current price of $2.48. The optimism is driven by the company's lead candidate, lanifibranor, in Phase 3 trials for MASH/NASH, a market with high unmet needs. However, UBS holds a more cautious "Hold" rating with a $3 target, reflecting some concerns about execution risks.

What is bear's view on IVA?

IVA stock currently trades at a low valuation, reflecting its financial challenges and reliance on clinical trial success. The stock price is $2.42, with a bearish outlook due to limited cash reserves (€13.9M as of Q3 2024) and high operational costs. Uncertainty around its Phase 3 trial results and financing risks weigh heavily on the stock.

IVA VS S&P500

Ask Intellectia about IVA

IVA Analyst's Forecast

Annabel Samimy

Stifel

Strong Buy

2024-11-22

Price Target

$20 → $17

Upside

+550.1%

Stifel lowered the firm's price target on Inventiva to $17 from $20 and keeps a Buy rating on the shares. The company removed its "biggest stock overhang" through an equity financing of up to EUR 348M in three tranches, the first of which was closed in October, the analyst tells investors. The firm, which notes cash is sufficient until Q2 of 2025 with access to future conditional tranches, reduced it price target to account for dilution.
Eliana Merle

UBS

Hold

2024-11-12

Price Target

$3

Upside

+13.64%

Annabel Samimy

Stifel

Strong Buy

2024-09-26

Price Target

$25 → $20

Downside

0%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free

Hot Stocks

stocks logo

GHC

Graham Holdings Co

$972.9
3.50%
stocks logo

HGV

Hilton Grand Vacations Inc

$40.51
0.10%
stocks logo

PYCR

Paycor HCM Inc

$22.15
-0.14%
stocks logo

JWN

Nordstrom Inc

$24.33
0.04%
stocks logo

SBRA

Sabra Health Care REIT Inc

$16.39
-0.18%
stocks logo

KOF

Coca-Cola Femsa SAB de CV

$86.59
-1.30%
stocks logo

BLKB

Blackbaud Inc

$65.9
-1.44%
stocks logo

CARG

CarGurus Inc

$31.21
0.42%
stocks logo

FLG

Flagstar Financial Inc

$12.08
0.83%
stocks logo

CNO

CNO Financial Group Inc

$40.86
1.54%